CEMEX, S.A.B. de C.V. (CX) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 6/100
- 10Y CAGR
- 36.3%
- Median YoY
- 5.7%
- YoY volatility
- σ 566.1pp· choppy
- Quarters ≥ 20%
- 6 of 40
- Negative quarters
- 15
- Valuation vs own 10Y history
- P/S 0.1x · 10Y median 0.7x · 1st percentile · as of Aug 19, 2026
How this score is computed
- Quarters at or above 20%: 6 of 40 → 6 of 40 pts
- Steadiness (typical swing 566.1pp) → 0 of 25 pts
- Pace (median 5.7% YoY) → 0 of 20 pts
- Latest quarter (11.3% YoY) → 0 of 15 pts
- Score: 6 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 36.3% | 5.7% | 566.1pp | 6 of 40 | 15 |
| EPSEPS | 63.6% | — | — | — | — |
| Op cash flowOperating cash flow | 6.4% | -2.4% | 66.2pp | 13 of 34 | 18 |
| EBITDAEBITDA | 37.4% | 6.9% | 316.4pp | 13 of 36 | 15 |
| FCFFree cash flow | 6.5% | -8.6% | 183.5pp | 12 of 32 | 17 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: CX on the compounders surface · All compounders, ranked